- Home
- RDIB vs ZTEK Comparison
RDIB vs ZTEK Comparison
Compare RDIB & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDIB
- ZTEK
- Stock Information
- Founded
- RDIB 1937
- ZTEK 2008
- Country
- RDIB United States
- ZTEK Canada
- Employees
- RDIB N/A
- ZTEK N/A
- Industry
- RDIB Movies/Entertainment
- ZTEK Major Chemicals
- Sector
- RDIB Consumer Discretionary
- ZTEK Industrials
- Exchange
- RDIB Nasdaq
- ZTEK Nasdaq
- Market Cap
- RDIB 140.2M
- ZTEK 165.9M
- IPO Year
- RDIB N/A
- ZTEK N/A
- Fundamental
- Price
- RDIB $9.51
- ZTEK $1.33
- Analyst Decision
- RDIB
- ZTEK
- Analyst Count
- RDIB 0
- ZTEK 0
- Target Price
- RDIB N/A
- ZTEK N/A
- AVG Volume (30 Days)
- RDIB 6.7K
- ZTEK 29.1K
- Earning Date
- RDIB 08-13-2025
- ZTEK 08-13-2025
- Dividend Yield
- RDIB N/A
- ZTEK N/A
- EPS Growth
- RDIB N/A
- ZTEK N/A
- EPS
- RDIB N/A
- ZTEK N/A
- Revenue
- RDIB $205,644,000.00
- ZTEK $44,936.00
- Revenue This Year
- RDIB $7.47
- ZTEK N/A
- Revenue Next Year
- RDIB $13.22
- ZTEK N/A
- P/E Ratio
- RDIB N/A
- ZTEK N/A
- Revenue Growth
- RDIB N/A
- ZTEK 92.38
- 52 Week Low
- RDIB $5.78
- ZTEK $0.50
- 52 Week High
- RDIB $21.34
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- RDIB 45.18
- ZTEK 36.79
- Support Level
- RDIB $9.00
- ZTEK $1.39
- Resistance Level
- RDIB $12.72
- ZTEK $1.55
- Average True Range (ATR)
- RDIB 1.33
- ZTEK 0.09
- MACD
- RDIB -0.12
- ZTEK -0.02
- Stochastic Oscillator
- RDIB 19.13
- ZTEK 2.04
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.